Section 639.67073 - Immediate-use sterile compounding: Preparation and labeling1. If an immediate-use sterile compounded drug product is not immediately administered by direct injection into a patient by the person who compounded it, the compounded drug product must bear a label which includes, without limitation:(a) The name and, if the patient has an identification number, the identification number of the patient;(b) The name and amount of each ingredient of the compounded drug product;(c) The initials of the person who compounded the compounded drug product; and(d) The exact date and time of expiration of the compounded drug product.2. An immediate-use sterile compounded drug product must not be stored for later use.Nev. Admin. Code § 639.67073
Added to NAC by Bd. of Pharmacy by R035-06, eff. 9-18-2008; A by R053-24A, eff. 10/23/2024